Advertisement

Pathology in the Cholinergic Basal Forebrain: Implications for Treatment

  • Peter J. Whitehouse
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 295)

Abstract

The development of effective treatments for the cognitive impairment characteristic of dementing illnesses represents a major challenge to neuroscientists in the future. Success in this endeavor will depend on understanding the biological basis of normal cognition. In order to make scientific progress in understanding the neural basis of cognition and the consequences of dysfunction in these systems in dementia, we must isolate components or subsystems in order to study them. As we make simplifying assumptions, we must remember the dangers of such simplication and the importance of eventually modelling the entire network of interacting systems that support normal thought and that are impaired in dementia.

Keywords

Basal Forebrain Quinolinic Acid Nucleus Basalis Ibotenic Acid Subacute Sclerosing Panencephalitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barde, Y-A, 19, Trophic factors and neuronal survival, Neuron,Google Scholar
  2. Bartus, R.T., Dean, R.L., Beer, B., Lippa, A.S., 1982, The cholinergic hypothesis of geriatric memory dysfunction. Science, 217:408–417.PubMedCrossRefGoogle Scholar
  3. Gage, F.H., Chen, K.S., Buzsaki, G., Armstrong, D., 1988, Experimental approaches to age related cognitive impairments, Neurobiol. Aging, 9:645.Google Scholar
  4. Gauthier, S., Bouchard, R., Lamontagne, A., Bailey, P., Bergman, H., Ratner, J., Tesfaye, Y., Saint-Martin, M., Bacher, Y., Carrier, L., Charbonneau, R., Clarfield, A.M., Collier, B., Dastoor, D., Gauthier, L., Germain, M., Kissel, C., Krieger, M., Kushnir, S., MAsson, H., Morin, J., Nair, V., Neirinck, L., and Suissa, S.,1990, Tetrahydroaminoacridine-Lecithin combination treatment in patients with intermediate-stage Alzheimer’s disease, N Engl J Med322:1272.PubMedCrossRefGoogle Scholar
  5. Hefti, F., Hartikka, J., Knusel, B.,1989, Function of neurotrophic factors in the adult and agingbrain and their possible use in the treatment of neurodegnerative diseases, Neurobiol. Aging, 10:515–533.Google Scholar
  6. Ishii, T., 1966, Distribution of Alzheimer’s neurofibrillary changes in the brain stem and hypothalamus of senile dementia, Acta. Neuropathol. 6:181.PubMedCrossRefGoogle Scholar
  7. Mash, D.C., Flynn, D.D., Potter, L.T., 1985, Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer’s and experimental cholinergic denervation. Science, 228:1117.CrossRefGoogle Scholar
  8. Olton, D.S., Gamzu, E., Corkin, S., 1985, Memory Dysfunctions: An Integration of Animal and Human Research from Preclinical and Clinical Perspectives. Annals of the New York Academy of SciencesVol. 444, 1985.Google Scholar
  9. Palmert, M.R., Golde, T.E., Cohen, M.L., Kovacs, D.M., Tanzi, R.E., Gusella, J.F., Usiak, M.F., Younkin, L.H., Younkin, S.G., 1990, Amyloid protein precursor messenger RNAs: Differential expression in Alzheimer’s disease. Science241:1080.CrossRefGoogle Scholar
  10. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergmann, K., Gibson, P.H. and Perry, R.H., 1976, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, Br. Med. J. 2:457.Google Scholar
  11. Ruberg, M., Ploska, A., Javoy-Agid, F., and Agid, Y., 1982, Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res. 232:129.PubMedCrossRefGoogle Scholar
  12. Shimohama, S., Taniguchi, T., Fujuwara, M. et al., 1985, Biochemical characterization of the nicotinic cholinergic receptors in human brain: Binding of (-)-[H]nicotine, J. Neurochem. 45:604.PubMedCrossRefGoogle Scholar
  13. Sunderland, T., Tariot, P.N., Newhouse, P.A.,1988, Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations, Brain Res13:371.CrossRefGoogle Scholar
  14. Whitehouse, P.J., Struble, R.G., Hedreen, J.C., Clark, A.W., Price, D.L., 1985, Alzheimer’s disease and related dementias: Selective involvement of specific neuronal systems, CRC Crit. Rev. Clin. Neurobiol. 1(4):319.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Peter J. Whitehouse
    • 1
  1. 1.Alzheimer Center and Department of NeurologyUniversity Hospitals and Case Western Reserve UniversityClevelandUSA

Personalised recommendations